Ravi Murthy, M.D., M.M.M., F.A.C.P., F.S.I.R.
Department of Interventional Radiology, Division of Diagnostic Imaging
About Dr. Murthy
Dr. Ravi Murthy joined MD Anderson in 2002 as an Assistant Professor in the Department of Interventional Radiology, Division of Diagnostic Imaging. He was subsequently promoted to Associate Professor in 2006 and Professor in 2012. Dr. Murthy is a Board Certified Interventional Radiologist with over 14 years’ experience in complex image guided procedures. Dr. Murthy’s research interests include Yttrium-90 microspheres for hepatic malignancies and image guided interventional trials. Clinical interests include General interventional radiology in oncology patients.
Present Title & Affiliation
Primary Appointment
Professor, Department of Diagnostic and Interventional Imaging, Division of Diagnostic Imaging, The University of Texas Medical School at Houston, Houston, TX
Professor, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor of Radiology, Department of Interventional Radiology and Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Division of Diagnostic Imaging, The University of Texas Medical School at Houston, Houston, TX
Professor, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor of Radiology, Department of Interventional Radiology and Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Yttrium-90 microspheres for hepatic malignancies and image guided interventional trials.
Education & Training
Degree-Granting Education
| 2018 | Carnegie Mellon University, Heinz College, Pittsburgh, Pennsylvania, US, Masters of Medical Management, MMM |
| 1989 | St. John's Medical College and Hospital, Bangalore, IN, MD |
Postgraduate Training
| 2018-2019 | Cancer Biology and Therapeutics, High Impact Cancer Research Program, Postgraduate Certificate Program, Harvard Medical School Postgraduate Medical Education, Boston, Massachusetts |
| 2012-2013 | Health Care Management Program, Rice University, Houston, Texas |
| 2002-2003 | Research Fellowship, Radiological Society of North America Fellowship, American College of Radiology, Reston, Virginia |
| 1997-1998 | Clinical Fellowship, Vascular & Interventional Radiology, State University of New York, Stony Brook, New York |
| 1993-1997 | Clinical Residency, Diagnostic Radiology, Morristown Memorial Hospital, Columbia Presbyterian College of Physicians & Surgeons, Morristown, New Jersey |
| 1991-1993 | Clinical Residency, Internal Medicine, Robert Wood Johnson University Hospital, New Brunswick, New Jersey |
| 1990-1991 | Internship: Internal Medicine, Internal Medicine, Mount Sinai School of Medicine, Elmhurst General Hospital, New York, New York |
| 1988-1989 | Rotating Internship, St. John's Medical College and Hospital, Bangalore |
Board Certifications
| 1999 | The American Board of Radiology, Diagnostic Radiology with Added Qualifications in Vascular and Interventional Radiology |
| 1997 | The American Board of Radiology, Diagnostic Radiology |
| 1993 | The American Board of Internal Medicine |
Experience & Service
Academic Appointments
Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2013
Associate Professor, Department of Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX, 2012 - 2021
Associate Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2012
Assistant Professor, Department of Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX, 2004 - 2012
Assistant Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2006
Assistant Professor, Department of Division of Hematology & Oncology, University of Maryland School of Medicine, Baltimore, MD, 1999 - 2002
Assistant Professor, Department of Division of Vascular and Interventional Radiology, University of Maryland School of Medicine, Baltimore, MD, 1998 - 2002
Assistant Instructor, University Hospital and Medical Center, State University of New York at Stony Brook, Stony Brook, NY, 1997 - 1998
Instructor, St. John's Medical College Hospital, Bangalore, 1990 - 1990
Other Appointments/Responsibilities
Consultantship, DSMB Monitoring Board, ASTRA - ZENECA, Research Triangle Park, NC, 2011 - 2015
Member, Neuroendocrine Tumors Clinical Trials Planning Meeting (NET-CTPM), Boston, MA, 2009 - 2009
Member, Radioisotope Infusion for Treatment of Liver Malignancies: Collaborative Guideline Committee (ACR, ASTRO & SIR), Columbus, OH, 2007 - 2007
Member, Radioembolization Brachytherapy Oncology Consortium (REBOC), Chicago, IL, 2006 - 2006
Member, Liver Microsphere Brachytherapy Consensus Panel, Symposium on Treatment of Metastatic Liver Cancers: James Cancer Hospital and Solove Institute, Columbus, OH, 2006 - 2006
Proctor, Sirtex Medical, Inc, Lake Forest, IL, 2002 - 2006
Institutional Committee Activities
Member, Faculty Senate, 2022 - 2025
Member, Academic Review Committee for the Division of Education & Training, 2022 - 2025
IRB4 Associate Member, Institutional Review Board 4, 2016 - 2016
Committee Member, CFRC, 2015 - Present
Member, DICRC, 2014 - 2016
Member, Hepatocellular Carcinoma Interdisciplinary Research Group (HIRG), 2009 - Present
Member, Multidisciplinary Adrenal Neoplasia Clinical and Research Program, 2009 - Present
Member, Clinical Research Committee, 2005 - 2008
Member, Multidisciplinary TheraSphere Training Program, US Sites, 2001 - 2003
Member, Educational Steering Committee, 2001 - 2002
Member, Performance Improvement Committee, 1999 - 2002
Member, Central Venous Catheter Management Committee, 1999 - 2002
Member, Vascular Surgery Performance Improvement Committee, 1999 - 2002
Honors & Awards
| 2020 | America's Most Honored Doctors - Top 10%, The American Registry |
| 2018 | Overseas Fellow of the Royal Society of Medicine, Royal Society of Medicine |
| 2018 | Castle Connolly Top Doctor, Castle Connolly Medical LTD |
| 2017 | Marquis Who's Who |
| 2017 | Albert Nelson Marquis Achievement Award, The Marquis Who's Who Publication Board |
| 2017 | Super Doctors Rising Stars Honoree, Super Doctors Rising Stars |
| 2016 | 2016 Best Poster Winner - Imaging Category, World Conference of Interventional Radiology (WCIO) 2016 |
| 2015 | Faculty Senator for Interventional Radiology, MDACC Faculty Senate |
| 2014 | Highly Commended Textbook Award, British Medical Association - Clinical Interventional Oncology |
| 2013 | Castle Connolly Top Doctor, Castle Connolly Medical LTD |
| 2008 | Letter of Appreciation, Seoul National University Hospital |
| 2006 | Distinguished Reviewer Award, Journal of Vascular and Interventional Radiology |
| 2004 | Clinical Trials Design Workshop, American Association of Cancer Research, American Society of Clinical Oncology |
| 2002 | Association of University Radiologists Academic Development Award |
| 2002 | Fellow, American College of Physicians |
| 1999 | Physician's Recognition Award, American Medical Association |
| 1996 | Chief Resident, Morristown Memorial Hospital |
| 1981 | High School Valedictorian, School Captain and National Merit Scholar |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Nelson BE, Naing A, Fu S, Sheth RA, Murthy R, Piha-Paul S. Potentiating Intratumoral Therapy With Immune Checkpoint Inhibitors: Shifting the Paradigm of Multimodality Therapeutics. Immuno-Oncology and Technology, 2024. e-Pub 2024.
- Phillips S, Singh S, Lizee G, Solis L, Welsh JW, Bassett RL, Beal LG, Kim PY, Murthy R, Talukder A, Lai IP, Patel S. A phase Ib study of endogenous T cell therapy using SLC45A2-specific CD8 memory T cells for patients with metastatic uveal melanoma. Journal of Clinical Oncology 41(16 Supplement), 2023. e-Pub 2023.
- Habibollahi P, Odisio BC, Gurusamy V, Kuban JD, Avritscher R, Abdelsalam ME, Chasen BA, Murthy R, Mahvash A. Temporary reversal of hepatoenteric collaterals during 90Y radioembolization planning and administration. Curr Oncol 29(12):9582-9592, 2022. e-Pub 2022. PMID: 36547167.
- Tang C, Msaouel P, Hara K, Choi H, Le V, Shah AY, Wang J, Jonasch E, Choi S, Nguyen QN, Das P, Prajapati S, Yu Z, Khan K, Powell S, Murthy R, Sircar K, Tannir NM. Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: A single-arm, single-centre, feasibility, phase 2 trial. Lancet Oncol 22(12):1732-1739, 2021. e-Pub 2021. PMID: 34717797.
- Haymaker C, Johnson DH, Murthy R, Bentebibel SE, Uemura MI, Hudgens CW, Safa H, James M, Andtbacka RHI, Johnson DB, Shaheen M, Davies MA, Rahimian S, Chunduru SK, Milton DR, Tetzlaff MT, Overwijk WW, Hwu P, Gabrail N, Agrawal S, Doolittle G, Puzanov I, Markowitz J, Bernatchez C, Diab A. Tilsotolimod with ipilimumab drives tumor responses in anti-PD-1 refractory melanoma. Cancer Discov 11(8):1996-2013, 2021. e-Pub 2021. PMID: 33707233.
- Muñoz NM, Williams M, Dixon K, Dupuis C, McWatters A, Avritscher R, Manrique SZ, McHugh K, Murthy R, Tam A, Naing A, Patel SP, Leach D, Hartgerink JD, Young S, Prakash P, Hwu P, Sheth RA. Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy. J Immunother Cancer 9(2):e001800, 2021. e-Pub 2021. PMID: 33589526.
- Janku F, Zhang HH, Pezeshki A, Goel S, Murthy R, Wang-Gillam A, Shepard DR, Helgason T, Masters T, Hong DS, Piha-Paul SA, Karp DD, Klang M, Huang SY, Sakamuri D, Raina A, Torrisi J, Solomon SB, Weissfeld A, Trevino E, DeCrescenzo G, Collins A, Miller M, Salstrom JL, Korn RL, Zhang L, Saha S, Leontovich AA, Tung D, Kreider B, Varterasian M, Khazaie K, Gounder MM. Intratumoral injection of clostridium novyi-NT spores in patients with treatment-refractory advanced solid tumors. Clin Cancer Res 27(1):96-106, 2021. e-Pub 2021. PMID: 33046513.
- Sheth RA, Murthy R, Hong DS, Patel S, Overman MJ, Diab A, Hwu P, Tam A. Assessment of image-guided intratumoral delivery of immunotherapeutics in patients with cancer. JAMA Netw Open 3(7):e207911, 2020. e-Pub 2020. PMID: 32725245.
- Tapia C, Aung PP, Roy-Chowdhuri S, Xu M, Ouyang F, Alshawa A, Hajjar J, Singh G, Yang V, Castillo L, Le H, Murthy R, Stephen B, Hess KR, Wistuba I, Naing A. Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors. J Immunother Cancer 8(1):e000665, 2020. e-Pub 2020. PMID: 32303619.
- Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC. Survival outcomes for yttrium-90 transarterial radioembolization with and without sorafenib for unresectable hepatocellular carcinoma patients. J Hepatocell Carcinoma 7:117-131, 2020. e-Pub 2020. PMID: 32984089.
- Sinn BV, Fu C, Lau R, Litton J, Tsai TH, Murthy R| Tam A, Andreopoulou E, Gong Y, Murthy R, Gould R, Zhang Y, King TA, Viale A, Andrade V, Giri D, Salgado R, Laios I, Sotiriou C, Marginean EC, Kwiatkowski DN, Layman RM, Booser D, Hatzis C, Vicente Valero V, Fraser Symmans W. SET ER/PR - A robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer. NPJ Breast Cancer 5:16, 2019. e-Pub 2019. PMID: 31231679.
- Odisio BC, Krampitz GW, Murthy R, Mahvash A, Javle M, Vauthey JN. Preoperative drainage for perihilar cholangiocarcinoma. Lancet Gastroenterol Hepatol 4(1):10-11, 2019. e-Pub 2019. PMID: 30527574.
- Subbiah V, Murthy R, Hong DS, Prins RM, Hosing C, Hendricks K, Kolli D, Noffsinger L, Brown R, McGuire M, Fu S, Piha-Paul S, Naing A, Conley AP, Benjamin RS, Kaur I, Bosch ML. Cytokines produced by dendritic cells administered intratumorally correlate with clinical outcome in patients with diverse cancers. Clin Cancer Res 24(16):3845-3856, 2018. e-Pub 2018. PMID: 30018119.
- Murthy R, Borges VF, Conlin A, Chaves J, Chamberlain M, Gray T, Vo A, Hamilton E. Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: A non-randomised, open-label, phase 1b study. Lancet Oncol 19(7):880-888, 2018. e-Pub 2018. PMID: 29804905.
- Odisio BC, Cox VL, Faria SC, Yamashita S, Shi X, Ensor J, Jones AK, Mahvash A, Gupta S, Tam AL, Vauthey JN, Murthy R. Prognostic value of incidental hypervascular micronodules detected on cone-beam computed tomography angiography of patients with liver metastasis. Eur Radiol 27(11):4837-4845, 2017. e-Pub 2017. PMID: 28484824.
- Abdelsalam ME, Mahvash A, Madoff DC, Odisio BC, Kuban JD, Avritscher R, Murthy R. Radioembolization in colorectal metastases: A review. Digestive Disease Interventions 01(03):208-217, 2017. e-Pub 2017.
- Gupta N, Patel A, Ensor J, Ahrar K, Ahrar J, Tam A, Odisio B, Huang S, Murthy R, Mahvash A, Avritscher R, McRae S, Sabir S, Wallace M, Matin S, Gupta S. Multiple renal artery pseudoaneurysms in patients undergoing renal artery embolization following partial nephrectomy: Correlation with renal nephrometry scores. Cardiovasc Intervent Radiol 40(2):202-209, 2017. e-Pub 2017. PMID: 27681271.
- Ahrar JU, Gupta S, Ensor JE, Mahvash A, Sabir SH, Steele JR, McRae SE, Avritscher R, Huang SY, Odisio BC, Murthy R, Ahrar K, Wallace MJ, Tam AL. Efficacy of a self-expanding tract sealant device in the reduction of pneumothorax and chest tube placement rates after percutaneous lung biopsy: A matched controlled study using propensity score analysis. Cardiovasc Intervent Radiol 40(2):270-276, 2017. e-Pub 2017. PMID: 27826786.
- Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO. Natural history of T1N0M0 hepatocellular carcinoma: Large-scale study in the United States. Oncology 93(4):233-242, 2017. e-Pub 2017. PMID: 28683459.
- Heilmann AM, Subbiah V, Wang K, Sun JX, Elvin JA, Chmielecki J, Sherman SI, Murthy R, Busaidy NL, Subbiah I, Yelensky R, Nangia C, Vergilio JA, Khan SA, Erlich RL, Lipson D, Ross JS, Miller VA, Shah MH, Ali SM, Stephens PJ. Comprehensive genomic profiling of clinically advanced medullary thyroid carcinoma. Oncology 90(6):339-346, 2016. e-Pub 2016. PMID: 27207748.
- Maiti A, Brown RE, Corn PG, Murthy R, Ganeshan DM, Tsimberidou AM, Subbiah V. Anti-tumor response to combined anti-angiogenic and cytotoxic chemotherapy in recurrent metastatic chromophobe renal cell carcinoma: Response signatures and proteomic correlates. Clin Genitourin Cancer 14(2):e187-93, 2016. e-Pub 2016. PMID: 26684814.
- Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO. Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma. J Hepatocell Carcinoma 2016(3):1-7, 2016. e-Pub 2016. PMID: 27574586.
- Kuban JD, Tam AL, Huang SY, Ensor JE, Philip AS, Chen GJ, Ahrar J, Murthy R, Avritscher R, Madoff DC, Mahvash A, Ahrar K, Wallace MJ, Nachiappan AC, Gupta S. The effect of needle gauge on the risk of pneumothorax and chest tube placement after percutaneous computed tomographic (CT)-guided lung biopsy. Cardiovasc Intervent Radiol 38(6):1595-602, 2015. e-Pub 2015. PMID: 25920917.
- Steele JR, Jones AK, Ninan EP, Clarke RK, Odisio BC, Avritscher R, Murthy R, Mahvash A. Why bundled payments could drive innovation: An example from interventional oncology. J Oncol Pract. e-Pub 2015. PMID: 25604596.
- Roberts NJ, Zhang L, Janku F, Collins A, Bai RY, Staedtke V, Rusk AW, Tung D, Miller M, Roix J, Khanna KV, Murthy R, Benjamin RS, Helgason T, Szvalb AD, Bird JE, Roy-Chowdhuri S, Zhang HH, Qiao Y, Karim B, McDaniel J, Elpiner A, Sahora A, Lachowicz J, Phillips B, Turner A, Klein MK, Post G, Diaz LA, Riggins GJ, Papadopoulos N, Kinzler KW, Vogelstein B, Bettegowda C, Huso DL, Varterasian M, Saha S, Zhou S. Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses. Sci Transl Med 6(249):249ra111, 2014. e-Pub 2014. PMID: 25122639.
- May BJ, Murthy R, Madoff DC. What's new in transarterial therapies for hepatocellular carcinoma?. Gastrointest Cancer Res 5(3 Supplement 1):S14-S19, 2012. e-Pub 2012. PMID: 22876334.
- Janne d'Othée B, Sofocleous CT, Hanna N, Lewandowski RJ, Soulen MC, Vauthey JN, Cohen SJ, Venook AP, Johnson MS, Kennedy AS, Murthy R, Geschwind JF, Kee ST. Development of a research agenda for the management of metastatic colorectal cancer: Proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 23(2):153-163, 2012. e-Pub 2012. PMID: 22264550.
- Mahvash A, Zaer N, Shaw C, Chasen B, Avritscher R, Murthy R. Temporary balloon occlusion of the common hepatic artery for administration of yttrium-90 resin microspheres in a patient with patent hepatoenteric collaterals. J Vasc Interv Radiol 23(2):277-280, 2012. e-Pub 2012. PMID: 22264555.
- Avritscher R, Wright KC, Javadi S, Uthamanthil R, Gupta S, Gagea M, Bassett RL, Murthy R, Wallace MJ, Madoff DC. Development of a large animal model of cirrhosis and portal hypertension using hepatic transarterial embolization: A study in swine. J Vasc Interv Radiol 22(9):1329-1334, 2011. e-Pub 2011. PMID: 21802316.
- Salem R, Lewandowski RJ, Gates VL, Nutting CW, Murthy R, Rose SC, Soulen MC, Geschwind JF, Kulik L, Kim YH, Spreafico C, Maccauro M, Bester L, Brown DB, Ryu RK, Sze DY, Rilling WS, Sato KT, Sangro B, Bilbao JI, Jakobs TF, Ezziddin S, Kulkarni S, Kulkarni A, Liu DM, Valenti D, Hilgard P, Antoch G, Muller SP, Alsuhaibani H, Mulcahy MF, Burrel M, Real MI, Spies S, Esmail AA, Raoul JL, Garin E, Johnson MS, Benson AB, Sharma RA, Wasan H, Lambert B, Memon K, Kennedy AS, Riaz A, Committee TA, Interventional Radiology IOTFOTSO. Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol 22(3):265-278, 2011. e-Pub 2011. PMID: 21353979.
- Gupta S, Bedikian AY, Ahrar J, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: Response, survival, and prognostic factors. Am J Clin Oncol 33(5):474-480, 2010. e-Pub 2010. PMID: 19935383.
- Gupta S, Sultenfuss M, Romaguera JE, Ensor J, Krishnamurthy S, Wallace MJ, Ahrar K, Madoff DC, Murthy R, Hicks ME. CT-guided percutaneous lung biopsies in patients with hematologic malignancies and undiagnosed pulmonary lesions. Hematol Oncol 28(2):75-81, 2010. e-Pub 2010. PMID: 19728397.
- Avritscher R, Krishnamurthy S, Ensor J, Gupta S, Tam A, Madoff DC, Murthy R, Hicks ME, Wallace MJ. Accuracy and sensitivity of computed tomography-guided percutaneous needle biopsy of pulmonary hilar lymph nodes. Cancer 116(8):1974-1980, 2010. e-Pub 2010. PMID: 20151422.
- Gayed I, Wahba H, Nunez R, Murthy R. Effect of Y-90 SirSpheres therapy for multiple liver metastases in a variety of tumors. J Cancer Sci Ther 2(2):043-046, 2010. e-Pub 2010.
- Kobayashi K, Szklaruk J, Trent JC, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME, Gupta S. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors. Am J Clin Oncol 32(6):574-581, 2009. e-Pub 2009. PMID: 19636238.
- Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF, Soulen MC, Assessment Committee SOIRT, Tumor Ablation TIWGOI. Transcatheter therapy for hepatic malignancy: Standardization of terminology and reporting criteria. J Vasc Interv Radiol 20(7 Suppl):S425-S434, 2009. e-Pub 2009. PMID: 19560030.
- Liu DM, Kennedy A, Turner D, Rose SC, Kee ST, Whiting S, Murthy R, Nutting C, Heran M, Lewandowski R, Knight J, Gulec S, Salem R. Minimally invasive techniques in management of hepatic neuroendocrine metastatic disease. Am J Clin Oncol 31(6):200-215, 2009. e-Pub 2009. PMID: 19346815.
- Jakobs TF, Hoffmann RT, Schrader A, Stemmler HJ, Trumm C, Lubienski A, Murthy R, Helmberger TK, Reiser MF. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. Cardiovasc Intervent Radiol 32(1):38-46, 2009. e-Pub 2009. PMID: 18575933.
- Fong Y, Hapreet W, Leung T, Warner R, Pennington K, Kalayoglu M, Hall M, Rose S, Smith R, Liu D, Murthy R, Kennedy A, Nutting C, Salem R, Gulec S. Integration of radiomicrosphere therapy into the contemporary management strategies for primary and metastatic liver cancer: Oncology expert opinions and recommendations. J Interv Onc 2:46-58, 2009. e-Pub 2009.
- Jakobs TF, Saleem S, Atassi B, Reda E, Lewandowski RJ, Yaghmai V, Miller F, Ryu RK, Ibrahim S, Sato KT, Kulik LM, Mulcahy MF, Omary R, Murthy R, Reiser MF, Salem R. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90 yttrium microspheres. Dig Dis Sci 53(9):2556-2563, 2008. e-Pub 2008. PMID: 18231857.
- Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Warner RR, Liu D, Palmedo H, Overton C, Jones B, Salem R. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: Early results in 148 patients. Am J Clin Oncol 31(3):271-279, 2008. e-Pub 2008. PMID: 18525307.
- Atassi B, Bangash AK, Lewandowski RJ, Ibrahim S, Kulik L, Mulcahy MF, Murthy R, Ryu RK, Sato KT, Miller FH, Omary RA, Salem R. Biliary sequelae following radioembolization with Yttrium-90 microspheres. J Vasc Interv Radiol 19(5):691-697, 2008. e-Pub 2008. PMID: 18440457.
- Kamat PP, Gupta S, Ensor JE, Murthy R, Ahrar K, Madoff DC, Wallace MJ, Hicks ME. Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases. Cardiovasc Intervent Radiol 31(2):299-307, 2008. e-Pub 2008. PMID: 17922160.
- Tam A, Krishnamurthy S, Pillsbury EP, Ensor JE, Gupta S, Murthy R, Ahrar K, Wallace MJ, Hicks ME, Madoff DC. Percutaneous image-guided splenic biopsy in the oncology patient: An audit of 156 consecutive cases. J Vasc Interv Radiol 19(1):80-87, 2008. e-Pub 2008. PMID: 18192471.
- Murthy R, Kamat P, Nunez R, Madoff DC, Gupta S, Salem R, Yao JC. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol 19(1):145-51, 2008. e-Pub 2008. PMID: 18192482.
- Tam A, Wagner-Bartak NA, Wallace MJ, Murthy R. Liver abscess after inadvertent transhepatic transgression during percutaneous fluoroscopy-guided gastrostomy. Clin Radiol 63(6):731-735, 2008. e-Pub 2008. PMID: 18455567.
- Jakobs TF, Hoffmann RT, Fischer T, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Reiser MF, Helmberger TK. Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol 19(5):683-90, 2008. e-Pub 2008. PMID: 18440456.
- Jakobs TF, Hoffmann RT, Dehm K, Trumm C, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Helmberger TK, Reiser MF. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol 19(8):1187-1195, 2008. e-Pub 2008. PMID: 18656012.
- Gupta S, Hicks ME, Wallace MJ, Ahrar K, Madoff DC, Murthy R. Outpatient management of post biopsy pneumothorax with small-caliber chest tubes: Factors affecting the need for prolonged drainage and additional interventions. Cardiovasc Intervent Radiol 31(2):342-348. e-Pub 2007. PMID: 18074173.
- Krishnan S, Briere TM, Dong L, Murthy R, Ng C, Balter P, Mohan R, Gillin MT, Beddar AS. Daily targeting of liver tumors: Screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapy. Med Phys 34(12):4591-4593, 2007. e-Pub 2007. PMID: 18196785.
- Murthy R, Eng C, Krishnan S, Madoff DC, Habbu A, Canet S, Hicks ME. Hepatic Yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. J Vasc Interv Radiol 18(12):1588-1591, 2007. e-Pub 2007. PMID: 18057297.
- Wallace MJ, Murthy R, Kamat PP, Moore T, Rao SH, Ensor J, Gupta S, Ahrar K, Madoff DC, McRae SE, Hicks ME. Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol 18(12):1500-7, 2007. e-Pub 2007. PMID: 18057284.
- Kennedy AS, Warner R, McNeillie P, Dezarnl WA, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Liu D, Overton C, Salem R. Radioembolization for neuroendocrine hepatic metastases. Cancer Investigation 25(1):55-56, 2007. e-Pub 2007.
- Kobayashi K, Gupta S, Trent JC, Vauthey JN, Krishnamurthy S, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, McRae SE, Hicks ME. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: Response, survival, and prognostic factors. Cancer 107(12):2833-2841, 2006. e-Pub 2006. PMID: 17096432.
- Kennedy AS, Coldwell D, Nutting C, Murthy R, Wertman DE, Loehr SP, Overton C, Meranze S, Niedzwiecki J, Sailer S. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA experience. Int J Radiat Oncol Biol Phys 65(2):412-25, 2006. e-Pub 2006. PMID: 16690429.
- Murthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, Hicks ME. Yttrium-90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results. J Vasc Interv Radiol 16(7):937-945, 2005. e-Pub 2005. PMID: 16002501.
- Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN. Transhepatic ipsilateral right portal vein embolization extended to segment IV: Improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16(2 Pt 1):215-225, 2005. e-Pub 2005. PMID: 15713922.
- Gupta S, Krishnamurthy S, Broemeling LD, Morello FA, Wallace MJ, Ahrar K, Madoff DC, Murthy R, Hicks ME. Small (<2-cm) subpleural pulmonary lesions: Short versus long needle path for computed tomography-guided biopsy of small pulmonary lesions: comparison of diagnostic yield and complications. Radiology 234(2):631-637, 2005. e-Pub 2005. PMID: 15673500.
- Ahrar K, Himmerich JU, Herzog CE, Raymond AK, Wallace MJ, Gupta S, Madoff DC, Morello FA, Murthy R, McRae SE, Hicks ME. Percutaneous ultrasound-guided biopsy in the definitive diagnosis of osteosarcoma. J Vasc Interv Radiol 15(11):1329-1333, 2004. e-Pub 2004. PMID: 15525755.
- Wallace MJ, Jean JL, Gupta S, Eapen GA, Johnson MM, Ahrar K, Madoff DC, Morello FA, Murthy R, Hicks ME. Inferior vena caval filters: Survival in patients with malignancy. Cancer 101(8):1902-1907, 2004. e-Pub 2004. PMID: 15386336.
- Murthy R, Arbabzadeh M, Richard H, Levitin A, Lund G, Stainken B. Endovascular technique for revision of excess catheter length in subcutaneous implanted venous access devices. Cardiovasc Intervent Radiol 27(3):259-261, 2004. e-Pub 2004. PMID: 15108022.
- Gupta S, Madoff DC, Ahrar K, Morello FA, Wallace MJ, Murthy R, Hicks ME. CT-guided needle biopsy of deep pelvic lesions by extraperitoneal approach through iliopsoas muscle. Cardiovasc Intervent Radiol 26(6):534-538, 2003. e-Pub 2003. PMID: 15061177.
- Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, Murthy R, Hicks ME, Ajani JA. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: The MD Anderson experience. Cancer J 9(4):261-267, 2003. e-Pub 2003. PMID: 12967136.
- Safriel Y, Murthy R, Kergosien Y. The ACR-RSNA fellowship in clinical trials of medical imaging: Reflections from the 2002 recipients. Acad Radiol 10(5):565-566, 2003. e-Pub 2003. PMID: 12755547.
- Sarkodee-Adoo C, Taran I, Guo C, Buadi F, Murthy R, Cox E, Lopez R, Westphal S, Shope S, O'Connell B, Wethers L, Meisenberg B. Influence of pre-apheresis clinical factors on the efficiency of CD34+ cell collection by large-volume apheresis. Bone Marrow Transplant 31(10):851-855, 2003. e-Pub 2003. PMID: 12748660.
- Sarfaraz M, Kennedy AS, Cao ZJ, Sackett GD, Yu CX, Lodge MA, Murthy R, Line BR, Van Echo DA. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys 30(2):199-203, 2003. e-Pub 2003. PMID: 12607837.
- Murthy R, Wesley BA, Coldwell DM. Totally implanted venous access device removal in interventional radiology. Clin Radiol 57(9):850-852, 2002. e-Pub 2002. PMID: 12384113.
- Murthy R. New horizons in oncologic embolotherapy. J Vasc Interv Radiol 13(2):P116-P123, 2002. e-Pub 2002.
- Richard HM, Hastings GS, Boyd-Kranis RL, Murthy R, Radack DM, Santilli JG, Ostergaard C, Coldwell DM. A randomized, prospective evaluation of the Tesio, Ash split, and Opti-flow hemodialysis catheters. J Vasc Interv Radiol 12(4):431-435, 2001. e-Pub 2001. PMID: 11287528.
- Richard HM, Richard HM, Coldwell DM, Coldwell DM, Boyd-Kranis RL, Boyd-Kranis RL, Murthy R, Murthy R, Van Echo DA, Van Echo DA. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Interv Radiol 12(3):373-375, 2001. e-Pub 2001. PMID: 11287517.
- Murthy R. Biosurgery for the treatment of localized cancers. Science Translational Medicine.
Invited Articles
- Murthy R, Kamat P, Nunez R, Salem R. Radioembolization of Yttrium-90 microspheres for hepatic malignancy. Semin Interv Radiol 25(1):48-57, 2008. e-Pub 2008.
- Avritscher R, de Baere T, Murthy R, Deschamps F, Madoff D. Percutaneous transhepatic portal vein embolization: Rationale, technique, and outcomes. Semin Interv Radiol 25:132-145, 2008. e-Pub 2008.
- Salem R, Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Ibrahim S, Nemcek AA, Omary RA, Madoff DC, Murthy R. Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol 10(1):12-29, 2007. e-Pub 2007. PMID: 17980315.
- Murthy R, Habbu A, Salem R. Trans-arterial hepatic radioembolization yttrium-90 microspheres. Biomed Imaging Interv J 2(3):1-10, 2006. e-Pub 2006.
- Wallace MJ, Murthy R. Transarterial therapy for patients with hepatic malignancy. Semin Interv Radiol 22:316-328, 2005. e-Pub 2005.
- Murthy R, Hastings GS, Richard HM III, Levitin A. Angiography and endovascular intervention for vascular trauma to the extremities. Semin Interv Radiol 20:81-88, 2003. e-Pub 2003.
Manuals, Teaching Aids, Other Teaching Publications
- Coldwell D, Murthy R, Nutting C, Salem R. Practice guideline for radioembolization with microsphere brachytherapy device (TMBD) for treatment of liver malignancies, 2008.
- Kennedy A, Nag S, Murthy R, Dezarn W, Nutting C, Coldwell D, Salem R, Liu D. Liver-directed radiotherapy using microspheres (radioembolization) for primary and metastatic cancers, 2008.
- Murthy R, Jakobs T. Spheres of progress in cancer treatment. Merion Publications, 2007.
- Murthy R. Radiotherapy with microspheres showcases latest research on microsphere therapy. East Valley Living Articles, 2006.
- Salem R, Kulik L, Murthy R. Radioembolization with Yttrium-90 microspheres for the treatment of hepatocellular carcinoma and liver metastases. US Gastroenterology Review, 2006.
- Murthy R. Irradiated microspheres lead to palliative option for unresectable liver cancer, 2001.
- Murthy R. Emergency Medicine Bulletin Board System, 2000.
Other Articles
- Nelson, BE, Naing, A, Fu, S, Sheth, RA, Murthy, R, Piha-Paul, SA Potentiating intratumoral therapy with immune checkpoint inhibitors. Immuno-Oncology and Technology 25, 2025. PMID: 39981134.
- Pal K, Kuban JD, Murthy R, Odisio BC, Metwalli ZA A sticky situation: Glue migration during hepatic vein embolization. Semin Intervent Radiol 40(3):254-257, 2023. PMID: 37484445.
- Tang, C, Msaouel, P, Hara, K, Choi, H, Le, V, Shah, AY, Wang, J, Jonasch, E, Choi, S, Nguyen, Q, Das, P, Prajapati, S, Yu, ZH, Khan, K, Powell, SF, Murthy, R, Sircar, K, Tannir, NM Definitive Radiotherapy in Lieu of Systemic Therapy for Oligometastatic Renal Cell Carcinoma: A Single-Arm, Single-Centre, Feasibility, Phase 2 Trial. Journal of Urology 208(1):210, 2022. PMID: 35469446.
- Murthy R, Rachakonda V, Bassuner J Refractory biliary catheter leak corrected by a hybrid closed loop catheter-pump system. Case Rep Radiol 2021(1):6677500, 2021. PMID: 33763277.
- Janku F, Zhang H, Pezeshki AM, Goel S, Murthy R, Wang-Gillam A, Shepard D, Helgason T, Masters T, Hong D, Piha-Paul S, Karp D, Klang M, Sakamuri D, Raina A, Torrisi J, Solomon S, Weissfeld A, Trevino E, DeCrescenzo G, Collins A, Miller M, Salstrom J, Korn R, Zhang L, Saha S, Leontovich A, Tung D, Kreider B, Varterasian M, Khazaie K, Gounder M Intratumoral injection of clostridium novyi-NT spores in patients with treatment-refractory advanced solid tumors: Results of a first-in-man dose-escalation study. Cancer Discovery, 2019.
- Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC Minimally invasive image-guided therapies for hepatocellular carcinoma. J Hepatocell Carcinoma 11(3):55-61, 2016. PMID: 27785450.
- Murthy R, Murthy R Early research: Genetically modified bacteria spores injected into solid tumors destroy cancer. Oncology Times 37:25-26, 2015.
- Atassi B, Bangash AK, Bahrani A, Pizzi G, Lewandowski RJ, Ryu RK, Sato KT, Gates VL, Mulcahy MF, Kulik L, Miller F, Yaghmai V, Murthy R, Larson A, Omary RA, Salem R Multimodality imaging following 90Y radioembolization: A comprehensive review and pictorial essay. Radiographics 28(1):81-99, 2008. PMID: 18203932.
- Gamblin CT, Murthy R Small beads, big hope - Radioembolization with microspheres targets liver cancer. Radiology Today 9(14):26, 2008.
- Abdalla EK, Denys A, Hasegawa K, Leung TW, Makuuchi M, Murthy R, Ribero D, Zorzi D, Vauthey JN, Torzilli G Treatment of large and advanced hepatocellular carcinoma. Ann Surg Oncol 15(4):979-985, 2008. PMID: 18236115.
- Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF, Soulen MC Transcatheter therapy for hepatic malignancy: Standardization of terminology and reporting criteria. J Vasc Interv Radiol 18(12):1469-1478, 2007. PMID: 18057279.
- Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, Bester L, Bilbao JI, Kennedy AS, Omary RA, Salem R Radioembolization with Y90 microspheres: Angiographic and technical considerations. Cardiovasc Intervent Radiol 30(4):571-592, 2007. PMID: 17516113.
- Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, Nunez R, Habbu A, Liu D, Ross W, Cohen AM, Censullo M Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol 18(4):553-61; quiz 562, 2007. PMID: 17446547.
- Gupta S, Henningsen JA, Wallace MJ, Madoff DC, Morello FA, Ahrar K, Murthy R, Hicks ME Percutaneous biopsy of head and neck lesions with CT guidance: Various approaches and relevant anatomic and technical considerations. Radiographics 27(2):371-390, 2007. PMID: 17374859.
- Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol 17(8):1235-1249; quiz 1250, 2006. PMID: 16923972.
- Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations, and potential complications. Radiographics 25 Suppl 1:S41-55, 2005. PMID: 16227496.
- Madoff DC, Denys A, Wallace MJ, Murthy R, Gupta S, Pillsbury EP, Ahrar K, Bessoud B, Hicks ME Splenic arterial interventions: Anatomy, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S191-211, 2005. PMID: 16227491.
- Kobayashi K, Murthy R, Madoff DC Acute endovascular stent-graft occlusion after treatment of an arterio ureteral fistula. J Vasc Interv Radiol 16(10):1409-1410, 2005. PMID: 16221916.
- Gupta S, Seaberg K, Wallace MJ, Madoff DC, Morello FA, Ahrar K, Murthy R, Hicks ME Imaging-guided percutaneous biopsy of mediastinal lesions: Different approaches and anatomic considerations. Radiographics 25(3):763-786; discussion 786-788, 2005. PMID: 15888624.
- Avritscher R, Madoff DC, Ramirez PT, Wallace MJ, Ahrar K, Morello FA, Gupta S, Murthy R, Wright KC, Hicks ME Fistulas of the lower urinary tract: Percutaneous approaches for the management of a difficult clinical entity. Radiographics 24(Suppl 1):S217-S236, 2004. PMID: 15486242.
- Gupta S, Nguyen HL, Morello FA, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME Various approaches for CT-guided percutaneous biopsy of deep pelvic lesions under CT guidance: Anatomic and technical considerations. Radiographics 24(1):175-189, 2004. PMID: 14730045.
- Rundback JH, Dorfman G, Safriel Y, Mauro M, Wright K, Bonn J, Farahani K, Murthy R Development of a research agenda for interventional oncology: Proceedings from an interdisciplinary consensus panel. J Vasc Interv Radiol 15(1 Pt 1):7-12, 2004. PMID: 14709681.
- Murthy R, Arbabzadeh M, Richard H, Levitin A, Lund G, Stainken B, Cooper C Axillary artery traumatic pseudoaneurysm managed with a Wallgraft endoprothesis. J Vasc Interv Radiol 14(1):117-118, 2003. PMID: 12525598.
- Murthy R, Arbabzadeh M, Lund G, Richard H, Levitin A, Stainken B Percutaneous transrenal hemodialysis catheter insertion. J Vasc Interv Radiol 13(10):1043-1046, 2002. PMID: 12397127.
Editorials
- Babiker H, Borazanci E, Subbiah V, Agarwala S, Algazi A, Schachter J, Lotem M, Maurice-Dror C, Hendler D, Rahimian S, Minderman H, Haymaker C, Mahadevan D, Bernatchez C, Murthy R, Hultsch R, Kaplan N, Woodhead G, Hennemeyer C, Chunduru S, Anderson PM, Diab A, Puzanov I. Tilsotolimod exploits the TLR9 pathway to promote antigen presentation and Type 1 IFN signaling in solid tumors: A Multicenter International Phase I/II trial (ILLUMINATE-101). Clin Cancer Res 28(23):5079-5087, 2022. PMID: 35917516.
- Murthy R, Szklaruk J. Invited commentary. Radiographics 25(Suppl 1):S97-S98, 2005.
Abstracts
- Chauhan N, Bukovcan J, Boucher E, Cosgrove D, Edeline J, Hamilton B, Hulik L, Master F, Salem R, Murthy R. Intra-arterial TheraSphere yttrium-90 glass microspheres in the treatment of patients with unresectable hepatocellular carcinoma: Protocal for the STOP-HCC phase 3 randomized controlled trial. Journal of Medical Internet Research, 2018. e-Pub 2018.
- Murthy R, Rachakonda V, Mahvash A, Huang SY, Sabir SH, Subbiah V, Janku F, Kaseb AO, Javie MM, Murth A. Percutaneous transhepatic biliary drainage in hepatopancreaticobiliary cancer: Contemporary efficacy. J Clin Oncol, 2016. e-Pub 2016.
- Murthy R. Intratumoural bacterial injections show tumour killing, first-in-man study demonstrates. Interventional News 2015(57):13, 2015. e-Pub 2015.
- Enriquez J, Javadi S, Murthy R, Ensor J, Mahvash A, Abdelsalam ME, Madoff DC, Wallace MJ, Avritscher R. Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: Incidence and predisposing technical factors in 142 patients. Acta Radiol 54(7):790 - 794, 2013. e-Pub 2013. PMID: 23535183.
- Neperud J, Mahvash A, Garg N, Murthy R, Szklaruk J. Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy?. World J Radiol 5(6):241-247, 2013. e-Pub 2013. PMID: 23807902.
- Overman MJ, Modak J, Kopetz S, Murthy R, Yao JC, Hicks ME, Abbruzzese JL, Tam AL. Use of research biopsies in clinical trials: Are risks and benefits adequately discussed?. J Clin Oncol 31(1):17-22, 2013. e-Pub 2013. PMID: 23129736.
- Smith J, Murthy R, Lahoti A, Odisio B, Avritscher R, Chasen B, Mahvash A. Temporary balloon occlusion of the common hepatic artery for yttrium-90 glass microspheres administration in a patient with hepatocellular cancer and renal insufficiency. Case Rep Radiol 2013:560758, 2013. e-Pub 2013. PMID: 23710405.
- Subbiah V, Murthy R, Anderson PM. [90Y] Yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases. J Clin Oncol 29(11):e292-e294, 2011. e-Pub 2011. PMID: 21245431.
- Ahrar J, Gupta S, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P, Bedikian AY. Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Invest 29(1):49-55, 2011. e-Pub 2011. PMID: 21166498.
- Murthy R, Mahvash R, Avritscher, Erwin W, Chasen B, Eng C. Yttrium microspheres with cituximab plus irinotecan for patients with advanced colorectal cancer metastases to liver. J Clin Oncol 28(15s):TPS197, 2010. e-Pub 2010.
- Briere TM, Beddar S, Balter P, Murthy R, Gupta S, Nelson C, Starkschall G, Gillin MT, Krishnan S. Respiratory gating with EPID-based verification: The MDACC experience. Phys Med Biol 54(11):3379-3391, 2009. e-Pub 2009. PMID: 19436104.
- Jakobs TF, Lewandowski RJ, Murthy R, Omary RA, Reiser MF, Salem R. Fibrosis, portal hypertension and hepatic volume changes induced by 90Yttrium radioembolization. J Vasc Interv Radiol 19(2 Suppl):S83, 2008. e-Pub 2008.
- Murthy R, Mutha P, Lee JH, Oh Y. Yttrium-90 labeled microsphere radioembolotherapy of liver-dominant metastases from thoracic malignancies. J Vasc Interv Radiol 19(2)(2 Pt 1):299-302, 2008. e-Pub 2008. PMID: 18341967.
- Murthy R, Kamat P, Nunez R, Madoff DC, Gupta S, Salem R, Yao JC. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol 19(1):145-151, 2008. e-Pub 2008. PMID: 18192482.
- Mutha P, Macapinlac H, Kamat P, Madoff DC, Gupta S, Ahrar K, Wallace M, Murthy R. Continued role of Tc 99m MAA scintigraphic detection of extrahepatic perfusion prior to initiating percutaneous trans-catheter hepatic artery chemotherapy. AJR Am J Roentgenol 190(4 Supplement, A52), 2008. e-Pub 2008.
- Tam A, Wagner-Bartak NA, Wallace MJ, Murthy R. Liver abscess after inadvertent transphepatic transgression during percutaneous fluoroscopy-guided gastrostomy. Clin Radiol 64(1):105, 2008. e-Pub 2008. PMID: 18455567.
- Krishnan S, Briere TM, Dong L, Murthy R, Ng C, Balter P, Mohan R, Gillin MT, Beddar AS. Daily targeting of liver tumors: Screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapy. Med Phys 34(12):4591-4593, 2007. e-Pub 2007. PMID: 18196785.
- Wallace MJ, Murthy R, Kamat PP, Moore T, Rao SH, Ensor J, Gupta S, Ahrar K, Madoff DC, McRae SE, Hicks ME. Impact of C-Arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol 18(12):1500-1507, 2007. e-Pub 2007. PMID: 18057284.
- Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68(1):13-23, 2007. e-Pub 2007. PMID: 17448867.
- Murthy R, Oh Y, Tam A, Gupta S, Madoff DC, Glisson B. Yttrium-90 microsphere treatment for liver dominant hepatic metastases from lung cancer. J Clin Oncol 24(18s):17122, 2006. e-Pub 2006.
- Kennedy AS, Coldwell D, Nutting C, Murthy R, Wertman DE, Loehr SP, Overton C, Meranze S, Niedzwiecki J, Sailer S. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA experience. Int J Radiat Oncol Biol Phys 65(2):412-425, 2006. e-Pub 2006. PMID: 16690429.
- Kobayashi K, Gupta S, Trent J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, McRae SE, Hicks ME. Hepatic artery chemoembolization in patients with metastatic gastrointestinal stromal tumors refractory to imatinib. J Vasc Interv Radiol 17:S77-S78, 2006. e-Pub 2006.
- Gupta S, Johnson MM, Murthy R, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: Variables affecting response rates and survival. Cancer 104(8):1590-1602, 2005. e-Pub 2005. PMID: 16134179.
- Madoff DC, Abdalla E, Gupta S, Tsung-Teh W, Morris JS, a D, Wallace M, Morello F, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey N. Transhepatic ipsilateral right portal vein embolization extended to segment IV: Improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16(2 (Pt1)):215-25, 2005. e-Pub 2005. PMID: 15713922.
- Murthy R, Arbabzadeh M, Richard H, Levitin A, Lund G, Stainken B. Endovascular technique for revision of excess catheter length in subcutaneous implanted venous access devices. Cardiovasc Intervent Radiol 27(3):259-261, 2004. e-Pub 2004. PMID: 15108022.
- Sarfaraz M, Kennedy AS, Cao ZJ, Sackett GD, Yu CX, Lodge MA, Murthy R, Line BR, Van Echo DA. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys 30(2):199-203, 2003. e-Pub 2003. PMID: 12607837.
- Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, Murthy R, Hicks ME, Ajani JA. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: The M.D. Anderson experience. Cancer J 9(4):261-267, 2003. e-Pub 2003. PMID: 12967136.
Book Chapters
- Odisio BC, Murthy R. Image-guided therapies for hepatocellular carcinoma. In: Hepatocellular carcinoma - future outlook. InTech - Open Access Publisher, 2013.
- Wallace MJ, Murthy R. Transarterial therapy in hepatic malignancy. In: Advanced Therapy in Endovascular Interventions, 2012.
- Murthy R, Mutha P, Gupta S. Yttrium 90 radioembolotherapy for hepatocellular cancer. In: Hepatocellular Carcinoma. Springer Science Business Media, LLC, 2010.
- Murthy R. Contribution - Radioembolization for hepatocellular cancer. In: Hepatocellular Carcinoma: A multidisciplinary approach. Springer, 2009.
Books (edited and written)
- Kee ST, Madoff DC, Murthy R. Clinical Interventional Oncology. Elsivier, 2013.
Letters to the Editor
- Murthy R, Mutha P, Madoff DC, Mahvash A, Erwin W. Establishment of the radiation effect of yttrium-90 microspheres: role of C-Arm CT. J Vasc Interv Radiol 20: 422-424, 2009.
- Murthy R, Kamat P, Staerkel G. Podagra. Internet Journal of Radiology 6, 2007.
- Murthy R, Arbabzadeh M, Richard H, Levitin A, Lund GA, Stainken B, Cooper C. Axillary artery traumatic pseudoaneurysm managed with a Wallgraft endoprosthesis. J Vasc Interv Radiol 14: 117-118, 2003.
Selected Presentations & Talks
Local Presentations
- 2012. Biologic therapies: What the interventional radiologist has to offer. Invited. The University of Texas MD Anderson Cancer Center. New York, New York, US.
- 2012. Colorectal cancer: Treatment and assessment of results. Invited. The University of Texas MD Anderson Cancer Center. New York, New York, US.
- 2012. Colorectal cancer: Interventional oncologist perspective. Invited. University of Texas MD Anderson Cancer Center. Houston, Texas, US.
- 2011. Yttrium 90 radioembolotherapy for hepatic malignancy. Invited. The University of Texas MD Anderson Cancer Center. Houston, Texas, US.
- 2010. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas. Invited. Nordic Neuroendocrine Symposium. Houston, Texas, US.
- 2009. Trans-arterial therapies for hepatocellular cancer. Invited. The CyFair Tumor Conference 2009. Houston, Texas, US.
- 2008. Radioembolization. Invited. The University of Texas MD Anderson Cancer Center. Houston, Texas, US.
- 2007. Bevacizumab is associated with a low incidence of femoral arteriotomy complications following percutaneous hepatic artery infusional chemotherapy procedures. Invited. Texas State Medical Oncology Society. Houston, Texas, US.
- 2007. Yttrium-90 microsphere therapy hepatocellular carcinoma: Eastern & western experiences. Invited. The University of Texas MD Anderson Cancer Center: 5th International Meeting. Houston, Texas, US.
- 2006. Yttrium-90 microsphere treatment for hepatic malignancy. Invited. Texas Gulf Coast Chapter of the American Radiological Nurses Association. Houston, Texas, US.
- 2006. Use of radioactive embolization for liver mets (SIR-Sphere). Invited. The University of Texas MD Anderson Cancer Center. Houston, Texas, US.
- 2004. Yttrium microspheres for liver cancer. Invited. Texas Gulf Coast Chapter of the American Radiological Nurses Association. Houston, Texas, US.
- 2004. Yttrium-90 microspheres in the treatment of liver cancer. Invited. The University of Texas MD Anderson Cancer Center. Houston, Texas, US.
Regional Presentations
- 2006. Liver directed radiotherapy with microspheres. Invited. Wake Oncology. Scottsdale, Arizona, US.
- 2006. Patient selection criteria for Y-90 microspheres: Limits and prevention of toxicities. Invited. University of Virginia Medical Center. Charlottesville, Virginia, US.
- 2005. Liver directed radiotherapy with microspheres: A clinical symposium. Invited. Wake Radiology Oncology Services. Boston, Massachusetts, US.
- 2005. Liver directed therapy with yttrium-90 microspheres. Invited. The Liver Institute at Methodist. Dallas, Texas, US.
- 2001. Transarterial hepatic brachytherapy. Invited. Maryland Society of Radiologic Technologists. Ocean City, Maryland, US.
- 2001. TheraSpheres in the treatment of primary and metastatic liver cancer. Invited. Baltimore Interventional Radiology Technologists Meeting. Baltimore, Maryland, US.
National Presentations
- 2024. Software-based quantitative measurement of drained liver volume after percutaneous biliary drain placement: A personalized 3D volumetry model. Poster. Proceedings of the Society of Interventional Radiology (SIR) 2024 Annual Scientific Meeting. Salt Lake City, Utah, US.
- 2023. A phase Ib study of endogenous T cell therapy using SLC45A2-specific CD8 T cells for patients with metastatic uveal melanoma. Poster. Proceedings of the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting. Chicago, Illinois, US.
- 2022. Radioembolization for HCC patients with personalized yttrium-90 dosimetry for curative intent (RAPY90D): Interim results. Poster. Proceedings of the Society of Interventional Radiology (SIR) 2022 Annual Scientific Meeting. Boston, Massachusetts, US.
- 2022. Metabolic complete responses (mCR) in metastatic uveal melanoma (mUM) patients treated with image-guided injection (IGI) of PV-10. Poster. Proceedings of the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Chicago, Illinois, US.
- 2022. PERIO-01: Enabling tumor microenvironment reprogramming by a TLR9 agonist using pressure enabled drug delivery to address intrahepatic immunosuppression and drug delivery barriers. Poster. Proceedings of the SITC Tumor Immune Microenvironment: A Holistic Approach Workshop. San Diego, California, US.
- 2021. Intratumoral CD40 agonist Sotigalimabin with pembrolizumab induces broad innate and adaptive immune activation in local and distant tumors in metastatic melanoma: Results of a phase 1/2 study. Poster. SITC 36th Annual Meeting. Washington, D.C, District of Columbia, US.
- 2020. Intra-tumor immunotherapy injections utilizing image guidance in interventional radiology: Clinical trial experience at a tertiary care cancer center. Poster. Proceedings of the SITC 2020 Virtual Annual Meeting. Milwaukee, Wisconsin, US.
- 2020. Real time image guided intra-tumor injection phase 1 clinical trials involving interventional radiology: Contemporary experience from a tertiary care cancer center. Poster. Proceedings of the FOCIS 2020 Virtual Annual Meeting. Menomonee Falls, Wisconsin, US.
- 2020. Intratumor immunotherapy injection: Early experience from a tertiary care cancer center. Poster. Proceedings of the 2020 Controlled Release Society Annual Meeting and Exposition. Las Vegas, Nevada, US.
- 2020. Oncolytic immunotherapy of hepatic tumors with intralesional rose bengal disodium. Poster. Proceedings of the Society of Interventional Radiology (SIR) 2020 Annual Meeting. Seattle, Washington, US.
- 2019. Intratumoral delivery of immunotherapeutics: Optimizing drug delivery for improved treatment efficacy. Poster. Society of Interventional Radiology (SIR) 44th Scientific and Annual Meeting. Austin, Texas, US.
- 2018. A Phase 2 study to evaluate the safety and efficacy of Intratumoral (IT) injection of the TLR9 agonist IMO-2125 (IMO) in combination with Ipilimumab (ipi) in PD-1 inhibitor refractory melanoma. Poster. Proceedings of the 2018 ASCO Annual Meeting. Chicago, Illinois, US.
- 2018. Phase I/II dose escalation and expansion cohort safety and efficacy study of image guided intratumoral CD40 agonistic monoclonal antibody APX005M in combination with systemic pembrolizumab for treatment naive metastatic melanoma. Poster. Proceedings of the 2018 ASCO Annual Meeting. Chicago, Illinois, US.
- 2018. Preliminary safety of deep/visceral (D/V) image guided (IG) intratumoral injection (ITI) of IMO-2125. Poster. Proceedings of the 2018 ASCO Annual Meeting. Chicago, Illinois, US.
- 2018. Radioembolization. Invited. Proceedings of the Cancer Imaging and Intervention Conference. Houston, Texas, US.
- 2018. Local intratumoral drug deliver for systemic immune activation. Invited. Proceedings of the Cancer Imaging and Intervention Conference. Houston, Texas, US.
- 2018. Immunotherapy trials in interventional oncology. Invited. 2018 Cancer Imaging and Intervention Conference (CIIC). Houston, Texas, US.
- 2017. Current clinical trials in immuno-oncology - An overview relevant for IO. Invited. Proceedings of the Radiological Society of North America (RSNA) 2017 Annual Meeting. Chicago, Illinois, US.
- 2017. Hepatocellular carcinoma and metastasis. Invited. Proceedings of the World Conference on Interventional Oncology (WCIO) 2017. Boston, Massachusetts, US.
- 2017. Cost effectiveness of percutaneous transhepatic biliary drainage catheters in malignant biliary obstruction: A financial analysis. Poster. Proceedings of the Society of Interventional Radiology (SIR) 2017 Annual Meeting. Washington, D.C, District of Columbia, US.
- 2016. Bacterial therapies & cancer. Invited. Proceedings of the World Conference on Interventional Oncology (WCIO) 2016. Boston, Massachusetts, US.
- 2016. Moderator: How I do it video workshop. Invited. Proceedings of the World Conference on Interventional Oncology (WCIO) 2016. Boston, Massachusetts, US.
- 2015. Intratumoural bacterial injections show tumour killing, first-in-man study demonstrates. Poster. 7th annual Symposium on Clinical Interventional Oncology, US.
- 2015. Phase 1 trial of image-guided oncolysis by Clostridium novyi-NT spore inoculation: Early technical insights. Invited. Proceedings of the ISET/CIO 2015. Hollywood, Florida, US.
- 2014. Activated autologous dendritic cells injected intratumorally are able to overcome local and systemic immune suppression imposed by the tumor and its microenvironment. Poster. Proceedings of the SITC 29th Annual Meeting. National Harbor, Maryland, US.
- 2013. Triaging therapeutic options in the HCC patients. Invited. 8th Annual SIR Fellows Spring Practicum. Evanston, Illinois, US.
- 2013. Y90 Radioembolization: How I Do It. Invited. 8th Annual SIR Fellows Spring Practicum. Evanston, Illinois, US.
- 2013. Tumor board: Metastatic disease (with live case). Invited. Proceedings of the World Conference on Interventional Oncology (WCIO) 2013. New York, New York, US.
- 2013. KRAS mutant metastatic colorectal cancer; Is there a role for Yttrium-90 microsphere radioembolotherapy?. Poster. Proceedings of the Society of Interventional Radiology (SIR) 2013 38th Annual Scientific Meeting. New Orleans, Louisiana, US.
- 2013. Neuroendocrine cancer: Then & now. Invited. Greater Louisville Radiologic Society at the University of Louisville. Louisville, Kentucky, US.
- 2013. Colorectal cancer: Interventional radiology options. Invited. Greater Louisville Radiologic Society at the University of Louisville. Louisville, Kentucky, US.
- 2012. Review of clinical trial research biopsies: A comparison of the expressed risks in the informed consents and observed biopsy-related adverse events. Poster. Proceedings of the 98th Annual Meeting of the Radiological Society of North America (RSNA). McCormick Place, Illinois, US.
- 2012. Y90. Y Not? Reasons Y90 is superior to TACE. Invited. Proceedings of the The Symposium on Clinical Interventional Oncology (CIO). Miami Beach, Florida, US.
- 2012. Drug-eluting embolics in liver mets: Choosing between doxorubicin and irinotecan, and the tumors to treat. Invited. Proceedings The Symposium on Clinical Interventional Oncology (CIO). Miami Beach, Florida, US.
- 2011. RCP on the management of metastatic colorectal cancer. Invited. The Society of Interventional Radiology (SIR). Herndon, Virginia, US.
- 2011. Y90 resin microsphere arterial radioembolotherapy as a therapeutic adjunct to systemic biologic therapy for advanced hepatic metastatic neuroendocrine tumor progression. Invited. Proceedings of the World Conference on Interventional Oncology. New York, New York, US.
- 2011. Management of challenging cases in interventional liver oncology: A case-based approach. Invited. Proceedings of the American Roentgen Ray Society Meeting. Chicago, Illinois, US.
- 2011. SS20 liver Y90. Invited. Proceedings of the 36th Annual Scientific Meeting of the Society of Interventional Radiology (SIR). Chicago, Illinois, US.
- 2011. Radioembolization liver metastatic disease portal vein embolization pre-surgery. Invited. The Sanctuary of Endovascular Therapy. Kiwah Island, South Carolina, US.
- 2011. SIRTUXIRI: Yttrium-90 radioembolotherapy with cetuximab and irinotecan in colorectal metastases (NCT00766220) initial results. Poster. Proceedings of the The Symposium on Clinical Interventional Oncology. Miami, Florida, US.
- 2011. A pictorial guide of great successes and failures in radioembolization. Invited. Proceedings of the The Symposium on Clinical Interventional Oncology. Miami, Florida, US.
- 2010. Taming the zebra: When and how to treat neuroendocrine tumor metastases to the liver. Invited. Proceedings of the 96th Annual Meeting of the Radiological Society of North America (RSNA). Chicago, Illinois, US.
- 2010. Yttrium microspheres with cetuximab plus irinotecan for patients with advanced colorectal cancer metastases to liver. Poster. The American Society of Clinical Oncology (ASCO). Chicago, Illinois, US.
- 2010. Embolotherapy for NET metastases: Bland, chemo, or yttrium. Invited. Proceedings of the 2010 World Conference on Interventional Oncology (WCIO). Philadelphia, Pennsylvania, US.
- 2010. Dosimetry. Invited. Proceedings of the 2010 World Conference on Interventional Oncology (WCIO). Philadelphia, Pennsylvania, US.
- 2010. Workshop: Applications of cone beam: CT in interventional oncology. Invited. Proceedings of the World Conference on Interventional Oncology. Philadelphia, Pennsylvania, US.
- 2010. Strategies and secrets in interventional oncology. Invited. Proceedings of the 35th Annual Scientific Meeting of the Society of Interventional Radiology. Tampa, Florida, US.
- 2010. Development of a large animal model for liver cirrhosis. Poster. Proceedings of the 35th Annual Scientific Meeting of The Society of Interventional Radiology. Tampa, Florida, US.
- 2009. Clinical experience with non-CRC metastases. Invited. Y-90 Radiomicrosphere Therapy of Liver Cancer 2009. Miami, Florida, US.
- 2009. Use of novel guidance systems for planning and performing percutaneous procedures. Poster. Proceedings of the 2009 Annual Meeting of the American Roentgen Ray Society. Boston, Massachusetts, US.
- 2009. Advanced Y90 radioembolotherapy workshop. Invited. Proceedings of the 34th Annual Scientific Meeting of the Society of Interventional Radiology. San Diego, California, US.
- 2009. Embolization in IO: TACE, bland, portal vein. Poster. Proceedings of the 2009 Society of Interventional Radiology (SIR) 34th Annual Scientific Meeting. San Diego, California, US.
- 2008. C-arm CT. Invited. Proceedings of the 38th Western Angiographic and Interventional Society Annual Meeting. Kapalua, Hawaii, US.
- 2008. Demographics, clinical profile, management and outcome of retinoblastoma. Poster. Proceedings of the 44th American Society of Clinical Oncology (ASCO) Annual Meeting. Chicago, Illinois, US.
- 2008. Workshop: Interventional plans and strategies. Invited. Proceedings of the Radiomicrosphere Therapy 4th Annual Symposium. Chicago, Illinois, US.
- 2008. Continued role of Tc99m MAA scintigraphic detection of extrahepatic perfusion prior to initiating percutaneous transcatheter hepatic artery chemotherapy. Poster. Proceedings of the American Roentgen Ray Society (ARRS) Annual Meeting. Washington, D.C, District of Columbia, US.
- 2008. Innovative imaging techniques in the IR suite. Invited. Proceedings of the Radiomicrosphere Therapy 4th Annual Symposium. Chicago, IL, US.
- 2008. Panel Discussion: Challenges and controversies in RMT-I: Expert opinions. Invited. Proceedings of the Radiomicrosphere Therapy 4th Annual Symposium. Chicago, Illinois, US.
- 2008. Principles and essentials of radiomicrosphere therapy. Invited. Proceedings of the Radiomicrosphere Therapy 4th Annual Symposium. Chicago, Illinois, US.
- 2008. Hepatic metastatic colorectal cancer patients with advanced disease appear to exhibit poor response rates to Y90 hepatic radioembolotherapy. Poster. Proceedings of the Radiomicrosphere Therapy 4th Annual Symposium. Chicago, Illinois, US.
- 2007. Dyna CT for hepatic malignancies. Invited. Proceedings of the 3rd Annual Microsphere Symposium. Chicago, Illinois, US.
- 2007. Primer on yttrium-90 microspheres. Invited. Proceedings of the 31st Annual Meeting Society of the Interventional Radiology. Seattle, Washington, US.
- 2007. Arterial embolization. Invited. Proceedings of the 31st Annual Meeting Society of the Interventional Radiology. Seattle, Washington, US.
- 2005. Feasibility of hepatic arterial therapy with yttrium-90 microspheres, SirSpheres, in metastatic neuroendocrine neoplasia with hepatic dominant progression after failure of multiple systemic and hepatic artery therapies. Invited. Proceedings of the 91st Annual Meeting of the Radiological Society of North America. Chicago, Illinois, US.
- 2002. Augmentation of hepatopulmonary shunting following trans arterial hepatic brachytherapy (TAHB) with yttrium-90 25µm spheres. Invited. Proceedings of the 88th Annual Meeting of the Radiological Society of North America. Chicago, Illinois, US.
- 2002. Clinical utility of Brehmstralung scan (BRM-scan) after TheraSphere (TS) (MDS Nordion, Kanata, Canada) administration. Invited. Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting. Baltimore, Maryland, US.
- 2002. Trans-arterial brachytherapy for hepatic malignancies utilizing particle emitting yttrium-90 microspheres. Invited. Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting. Baltimore, Maryland, US.
- 2002. Technical aspects of TheraSphere (TS) infusion (MDS Nordion, Kanata, Canada). Invited. Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting. Baltimore, Maryland, US.
- 2002. Plenary session: New horizons in oncological embolotherapy. Invited. Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting. Baltimore, Maryland, US.
- 2001. Safety and feasibility of ultrasound guided and fluoroscopic assisted PICC line insertion (UFPI) by a team of nurses functioning under the aegis of interventional radiology (IR). Invited. Proceedings of the 87th Annual Meeting of the Radiological Society of North America. Chicago, Illinois, US.
- 2001. Clinical practice and management workshop. Invited. Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting. Baltimore, Maryland, US.
- 2001. Advances in the treatment of liver cancer: A multidisciplinary and multimodality approach. Invited. Society for Interventional Radiology. Boston, Massachusetts, US.
International Presentations
- 2024. A phase Ib study of endogenous T cell therapy using SLC45A2-specific CD8 memory T cells for patients with metastatic uveal melanoma. Poster. 58th Ophthalmic Oncology Group. Stockholm, SE.
- 2023. Percutaneous autolytic immunotherapy for metastatic uveal melanoma in patients with hepatic metastases. Poster. 20th International Congress of the Society for Melanoma Research. Philadelphia, US.
- 2020. Tilsotolimod engages the TLR9 pathway to promote antigen presentation and Type I IFN signaling in solid tumors. Poster. Proceedings of the European Society for Medical Oncology (ESMO) Virtual Congress 2020. Lugano, CH.
- 2018. Tumor burden and lymphocytic infiltrate in on-treatment biopsies is significantly associated with response to Pembrolizumab in patients with rare tumors. Poster. USCAP 2018 Annual Meeting. Vancouver, CA.
- 2016. Phase I clinical study of intratumoral injection of oncolytic Clostridium novyi-NT spores in patients with advanced cancers. Poster. Proceedings of the 28th EORTC-NCI-AACR Symposium 2016. Munich, DE.
- 2015. Immunology for interventional radiologist and immunotherapy. Invited. Proceedings of the Western Angiographic & Interventional Society (WAIS) 2015. Vancouver, CA.
- 2012. Yttrium-90 microsphere radioembolotherapy for adolescent hepatic malignancies: Early experience at MD Anderson Cancer Center. Poster. Society for Pediatric Interventional Radiology (SPIR). Toronto, CA.
- 2012. Absorbed dose differences in 90Y microsphere therapy between pre-treatment 99m Tc-MAA and post-treatment 90Y scans. Poster. The Society of Nuclear Medicine and Molecular Imaging (SNMMI). Vancouver, CA.
- 2011. Imaging patterns of neuroendocrine tumor hepatic metastases as a predictor of response to yttrium-90 radioembolotherapy. Invited. Proceedings of the World Conference on Interventional Oncology. New York, US.
- 2011. AZUR detachable coil - Practical case discussion I. Invited. Proceedings of the Global Embolization Symposium and Technologies. Paris, FR.
- 2010. Quantification of hepatopulmonary shunting using C-Arm CT: Potential implications for Y90 radioembolotherapy program. Poster. Proceedings of the World Conference on Interventional Oncology Annual Meeting. Philadelphia, US.
- 2009. International radiology treatment of HCC: Combination therapy. Invited. Proceedings of the 2009 Annual Meeting American Roentgen Ray Society. Boston, US.
- 2008. Yttrium-90 radioembolotherapy for hepatic neoplasia. Invited. Proceedings of the 2008 SCCC International Liver Cancer Symposium. Seoul, KR.
- 2008. Can percutaneous hepatic artery infusional chemotherapy procedures be safely performed with concomitant systemic bevacizumab therapy?. Poster. Proceedings of the 3rd International Symposium on Regional Cancer Therapies Conference. Desert Springs, US.
- 2007. Hepatic metastatic neuroendocrine carcinomas treated with Y-90 microspheres. Poster. Proceedings of the 2nd International Symposium on Regional Cancer Therapies. San Juan, US.
- 2006. New horizons in the imaging of hepatic angiogenesis: Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations, and potential complications. Invited. Proceedings of the United European Gastroenterology Federation Annual Meeting. Berlin, DE.
- 2001. Hepatic vein hemodynamic assessment predicts pathological finding at transjugular liver biopsy. Invited. Proceedings of the Annual Meeting and Postgraduate Course, Cardiovascular and Interventional Radiological Society of Europe. Istanbul, TR.
- 2001. Feasibility of TrapEase inferior vena cava (IVC) filter insertion using single venous puncture and intravascular ultrasound (IVUS) guidance. Invited. Proceedings of the Annual Meeting and Postgraduate Course, Cardiovascular and Interventional Radiological Society of Europe. Istanbul, TR.
- 2000. Tunneled central venous catheter insertion in patients with thrombocytopenia. Invited. Society of Vascular Medicine and Biology. Toronto, CA.
Formal Peers
- 2011. Yttrium 90 hepatic radioembolotherapy. Visiting. Morristown Memorial Hospital. Morristown, New Jersey, US.
- 2009. Clinical experience with non-CRC metastases. Visiting. Florida International College of Medicine and Jackson International Memorial Hospital. Miami, Florida, US.
- 2009. Clinical evaluation and patient selection criteria. Visiting. Florida International College of Medicine and Jackson International Memorial Hospital. Miami, Florida, US.
- 2001. TheraSpheres in the treatment of primary and metastatic liver cancer. Invited. Wake Forest University School of Medicine. Winston-Salem, North Carolina, US.
- 2000. Management of hemodialysis access by interventional radiology. Invited. Lakeside Educational Trust. Bangalore, IN.
- 1999. Central venous access. Invited. State University of New York. Stony Brook, New York, US.
- 1998. Uterine fibroid embolization. Invited. State University of New York. Stony Brook, New York, US.
Grant & Contract Support
| Date: | 2014 - 2014 |
| Title: | Pilot study to evaluate the effect of molecular targeted anti-cancer agents on intra-tumoral pressure |
| Funding Source: | Mike Hogg Fund |
| Role: | PI |
| Date: | 2013 - 2016 |
| Title: | Temsirolimus with metformin in PI3 CA /RAS RAF mutant endometrial patients |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | PA-11-260 |
| Date: | 2012 - 2022 |
| Title: | Phase I Study of Temsirolimus in Combination With Metformin in Patients With Advanced Cancers |
| Funding Source: | University of Texas MD Anderson Cancer Center |
| Role: | Contributor |
| ID: | NCT01529593 |
| Date: | 2008 - 2012 |
| Title: | Subintimal Angioplasty - Application for limb salvage in renal transplant recipients with critical limb ischemia |
| Funding Source: | Burroughs Welcome Research Travel Grant |
| Role: | PI |
| Date: | 2006 - 2008 |
| Title: | Phase II trial of SIR-Spheres, yttrium microspheres with cetuximab plus irinotecan for patients with advanced colorectal cancer metastases to liver |
| Funding Source: | Sirtex Medical |
| Role: | PI |
| ID: | CS2005-00013199LE |
| Date: | 2006 - 2008 |
| Title: | Yttrium-90 microspheres (SIR-Spheres,,μ) therapy for the treatment of unresectable hepatocellular carcinoma |
| Funding Source: | Sirtex Medical |
| Role: | PI |
| ID: | CS2006-00015970SP |
| Title: | UT System Lean Life Science Cohort |
| Funding Source: | NSF |
| Role: | PI |
Patient Reviews
CV information above last modified March 31, 2025